Access brought to you by: LOCKSS

Cerebrovascular Disease Clinical Trials

No Added Benefit from EC-IC Bypass Surgery When Added to Standard Medical Therapy in Preventing Recurrence of Ipsilateral Stroke
Severity of Deficit Strongly Predicts Long-Term Survival among Stroke Survivors
Results from the LEAPS Trial
ROCKET-AF: Rivaroxaban Prevents Stroke as Effectively as Warfarin, with Lower Bleeding Risk
Results from the ACCORD BP Trial
New Data from RE-DEEM and RE-LY
Final Results of an FDA-approved Prospective, Multicenter, Single-Arm Trial of Stent-Assisted Recanalization for Acute Ischemic Stroke
The Results of NEST-2: A Double-Blind, Randomized, Phase III Study Evaluating the Safety and Efficacy of Transcranial Laser Therapy for Acute Ischemic Stroke within 24 Hours of Stroke Onset
Eligibility for rt-PA within a Population: The Effect of the ECASS-3 Trial
Insights from the ATACH Trial

Pages